The Gyeonggi Provincial Government is recruiting companies to participate in its "Public Medical Center Demonstration Support Project" to help AI diagnostic support device companies in the province enter the medical field and achieve commercialization.


This project utilizes Gyeonggi Provincial Medical Center as a testbed for AI medical devices, providing a platform for small and medium-sized enterprises (SMEs) based in the province to demonstrate their AI diagnostic support devices in real public healthcare settings. Medical staff at Gyeonggi Provincial Medical Center will directly use these AI diagnostic support devices to evaluate their effectiveness, user convenience, safety, and suitability for public healthcare. Participating companies will receive a demonstration result report, public reference, and support for product improvement and commercialization strategy development.


Gyeonggi Provincial Government

Gyeonggi Provincial Government

View original image

Eligible applicants are SMEs with their headquarters, factories, or research institutes located in Gyeonggi Province as of the announcement date, and that manufacture AI diagnostic support devices approved by the Ministry of Food and Drug Safety. Companies must also have domestic products that are capable of entering the general hospital-level market. Supported fields include AI-based diagnostic support devices, imaging analysis software, and clinical decision support systems.



Um Kiman, Director of the Bio Industry Division at the Gyeonggi Provincial Government, stated, "AI diagnostic support devices are a promising field that can reduce the diagnostic burden on medical professionals and improve the quality of medical services. By utilizing the medical field infrastructure of public medical centers, we will help local companies secure reliable demonstration references and enhance their market entry potential."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing